UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura

International journal of hematology, 2001-07, Vol.74 (1), p.101-108

2001

Volltextzugriff (PDF)

Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (3), p.251-259

2007

Volltextzugriff (PDF)

Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation

Bone marrow transplantation (Basingstoke), 2002-05, Vol.29 (9), p.789-794

2002

Volltextzugriff (PDF)

ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage

Blood, 2003-11, Vol.102 (9), p.3232-3237

2003

Volltextzugriff (PDF)

Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital

Clinical and experimental rheumatology, 2006-07, Vol.24 (4), p.454

2006

Volltextzugriff (PDF)

Plasma of patients with Upshaw–Schulman syndrome, a congenital deficiency of von Willebrand factor‐cleaving protease activity, enhances the aggregation of normal platelets under high shear stress

British journal of haematology, 2001-12, Vol.115 (4), p.991-997

2001

Volltextzugriff (PDF)

Platelets Treated with Ticlopidine Are Less Reactive to Unusually Large von Willebrand Factor Multimers than Are Those Treated with Aspirin under High Shear Stress

Pathophysiology of haemostasis and thrombosis, 2005-01, Vol.34 (1), p.35-40

2005

Volltextzugriff (PDF)

Thrombotic thrombocytopenic purpura associated with polyarteritis nodosa

Clinical nephrology, 2005-10, Vol.64 (4), p.305

2005

Volltextzugriff (PDF)

Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome

Blood, 2004-02, Vol.103 (4), p.1305-1310

2004

Volltextzugriff (PDF)

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

Seminars in hematology, 2004, Vol.41 (1), p.68-74

2004

Volltextzugriff (PDF)

Simple plasma exchange reduced autoantibody to von Willebrand factor‐cleaving protease in a Japanese man with ticlopidine‐associated thrombotic thrombocytopenic purpura

Journal of internal medicine, 2002-03, Vol.251 (3), p.280-281

2002

Volltextzugriff (PDF)

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

Transfusion (Philadelphia, Pa.), 2002-05, Vol.42 (5), p.572-580

2002

Volltextzugriff (PDF)

Decreased ADAMTS13 Levels in Patients after Living Donor Liver Transplantation

Thrombosis research, 2009-11, Vol.124 (5), p.541-545

2009

Volltextzugriff (PDF)

Decreased Activity of Plasma ADAMTS13 May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients with Alcoholic Hepatitis

Alcoholism, clinical and experimental research, 2005-12, Vol.29 (s3), p.264S-271S

2005

Volltextzugriff (PDF)

Von Willebrand factor—Cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: A case report

Liver transplantation, 2003-12, Vol.9 (12), p.1328-1333, Article ajlts09021

2003

Volltextzugriff (PDF)

Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura

International journal of hematology, 2005-06, Vol.81 (5), p.433-436

2005

Volltextzugriff (PDF)

Mechanisms underlying the age-related decrement in the human sweating response

European journal of applied physiology, 1999, Vol.79 (2), p.121-126

1999

Volltextzugriff (PDF)

Role and Regulation of Interleukin (IL)-2 Receptor α and β Chains in IL-2-Driven B-Cell Growth

Proceedings of the National Academy of Sciences - PNAS, 1992-04, Vol.89 (8), p.3551-3555

1992

Volltextzugriff (PDF)

Effect of Muscular Exercise by Bicycle Ergometer on Erythrocyte Purine Nucleotides

Hormone and metabolic research, 1994-11, Vol.26 (11), p.504-508

1994

Volltextzugriff (PDF)

Successful treatment of a young infant who developed high‐titer inhibitors against VWF‐cleaving protease (ADAMTS‐13): Important discrimination from Upshaw‐Schulman syndrome

American journal of hematology, 2002-12, Vol.71 (4), p.318-322

2002

Volltextzugriff (PDF)

Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity

International journal of hematology, 2001-10, Vol.74 (3), p.347-351

2001

Volltextzugriff (PDF)

Estimation of total oxygen uptake in women during exercise by total heart beats and aerobic fitness

Journal of sports medicine and physical fitness, 1990-06, Vol.30 (2), p.147

1990

Volltextzugriff (PDF)

Letters to the editor: Simple plasma exchange reduced autoantibody to von Willebrand factor-cleaving protease in a Japanese man with ticlopidine-associated thrombotic thrombocytopenic purpura

Journal of internal medicine, 2002-03, Vol.251 (3), p.280

2002

Volltextzugriff (PDF)

Intensive plasma IgG removal therapy for severe thrombotic thrombocytopenic purpura

International journal of hematology, 2002-12, Vol.76 (5), p.474-476

2002

Volltextzugriff (PDF)

Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation

Bone marrow transplantation (Basingstoke), 2002-05, Vol.29 (9), p.789

2002

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(11)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(25)
Life Sciences & Biomedicine
(25)
Adamts13 Protein
(19)
Female
(18)
Hematology
(16)
Male
(16)
Adult
(15)
Biological And Medical Sciences
(15)
Adam Proteins
(13)
Medical Sciences
(13)
Aged
(10)
Middle Aged
(9)
Hematologic And Hematopoietic Diseases
(8)
Platelet Diseases And Coagulopathies
(8)
Metalloendopeptidases - Blood
(6)
Adam Proteins - Blood
(5)
Adolescent
(5)
Metalloendopeptidases - Metabolism
(5)
Purpura, Thrombotic Thrombocytopenic - Blood
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura

Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels

Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation

ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage

Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital

Plasma of patients with Upshaw–Schulman syndrome, a congenital deficiency of von Willebrand factor‐cleaving protease activity, enhances the aggregation of normal platelets under high shear stress

Platelets Treated with Ticlopidine Are Less Reactive to Unusually Large von Willebrand Factor Multimers than Are Those Treated with Aspirin under High Shear Stress

Thrombotic thrombocytopenic purpura associated with polyarteritis nodosa

Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

Simple plasma exchange reduced autoantibody to von Willebrand factor‐cleaving protease in a Japanese man with ticlopidine‐associated thrombotic thrombocytopenic purpura

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

Decreased ADAMTS13 Levels in Patients after Living Donor Liver Transplantation

Decreased Activity of Plasma ADAMTS13 May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients with Alcoholic Hepatitis

Von Willebrand factor—Cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: A case report

Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura

Mechanisms underlying the age-related decrement in the human sweating response

Role and Regulation of Interleukin (IL)-2 Receptor α and β Chains in IL-2-Driven B-Cell Growth

Effect of Muscular Exercise by Bicycle Ergometer on Erythrocyte Purine Nucleotides

Successful treatment of a young infant who developed high‐titer inhibitors against VWF‐cleaving protease (ADAMTS‐13): Important discrimination from Upshaw‐Schulman syndrome

Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity

Estimation of total oxygen uptake in women during exercise by total heart beats and aerobic fitness

Letters to the editor: Simple plasma exchange reduced autoantibody to von Willebrand factor-cleaving protease in a Japanese man with ticlopidine-associated thrombotic thrombocytopenic purpura

Intensive plasma IgG removal therapy for severe thrombotic thrombocytopenic purpura

Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation

Suchergebnisse filtern